Answers are grounded in this paper and cite their sources.
Tumor lysis syndrome (TLS) is an oncological emergency that occurs when cancer cells are rapidly destroyed, causing metabolic disturbances and potentially life-threatening complications. It is essential to promptly prevent and recognize TLS to ensure effective management. TLS can lead to endothelial dysfunction, hyperuricemia, and/or acute renal failure. Additionally, it commonly manifests as metabolic imbalances such as hyperkalemia, hyperphosphatemia, and hypocalcemia. In this review, we aim to offer a comprehensive understanding of TLS, including its epidemiology, pathophysiology, risk factors, and clinical presentation.
No takes yet. Share an insight, caveat, or question.
Al-abbadi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: